BioPharmSignal logoBioPharmSignal

Biotech News

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MiMedx (MDXG)MiMedxConference / presentation

MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23 rd Annual Institutional Investor Conference on Thursday, May 28, 2026 in Minneapolis, MN.

Related news

CHRSCoherus BioSciences, Inc.2026-02-23 14:30 EST

Coherus Oncology to Participate in Upcoming Investor Conferences

ENTXEntera Bio2026-07-31 20:30 EST

Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

CHRSCoherus BioSciences, Inc.2026-01-06 14:30 EST

Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference

IBIOIbio Inc2025-11-24 21:15 EST

iBio to Participate in the 8th Annual Evercore Healthcare Conference

IBIOIbio Inc2025-10-23 11:00 EST

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

MDXGMiMedx2026-07-29 20:07 EST

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MDXGMiMedx2026-05-08 12:00 EST

MIMEDX Announces Launch of G4Derm® Plus

ADMAADMA Biologics2026-01-05 12:00 EST

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

STTKShattuck Labs2025-04-02 21:00 EST

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference

ENTXEntera Bio2025-06-25 12:00 EST

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

View all latest news

MiMedx

Placental Tissue Products MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair. Wound-Care Portfolio The company has more than a decade of experience...

Recent company news

MDXGMiMedx2026-07-29 20:07 EST

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MDXGMiMedx2026-07-29 20:01 EST

MIMEDX to Acquire Sanara MedTech

MDXGMiMedx2026-07-20 12:00 EST

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MDXGMiMedx2026-05-21 12:45 EST

MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference

MDXGMiMedx2026-05-08 12:00 EST

MIMEDX Announces Launch of G4Derm® Plus

Stock data

Close
4.18 USD
Market cap
531.74M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States